Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home LH testing vs hCG trigger in frozen embryo transfer
NCT03115320Phase 4Terminated
- Sponsor
- Tampere University Hospital
- Start
- Jan 2017
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human chorionic gonadotropin in infertility (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Live birth rate at 40 weeks. Started Jan 2017; status: terminated.
02
Drugs
human chorionic gonadotropin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03115320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03115320.